AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 11199506
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no PDE III inhibitor)
Trial: 1728484
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg amrinone
Trial: 1728484
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg amrinone (after digoxin infusion)
Trial: 6374931
Drug: Sotalol hydrochloride
RxNorm normalized name: Sotalol Hydrochloride
DrugBank: Sotalol (DB00489)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sotalol hydrochloride 160 mg/d plus hydrochlorothiazide 25 mg/d
Trial: 6374931
Drug: Reserpine 0.1
RxNorm normalized name: reserpine 0.1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reserpine 0.1 mg/d plus hydrochlorothiazide 25 mg/d
Trial: 22995464
Drug: Royal Jelly
RxNorm normalized name: ROYAL JELLY
DrugBank: Royal jelly (DB14250)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Royal Jelly (RJ) 3000 mg in 100 ml liquid/day for 6 months
Trial: 8544420
Drug: symptomatic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: symptomatic therapy
Trial: 25511347
Drug: Paracetamol group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol group
Trial: 25511347
Drug: Preemptive paracetamol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preemptive paracetamol group
Trial: 21817105
Drug: Intravenous lipids
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous lipids
Trial: 21817105
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no intravenous lipids)
Trial: 12736088
Drug: D-cycloserine (daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D-cycloserine (daily oral dose of 50 mg)
Trial: 10912746
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg trandolapril once daily for 6 weeks
Trial: 10912746
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg losartan once daily for 6 weeks
Trial: 9378688
Drug: Melatonin 10
RxNorm normalized name: melatonin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin 10 mg q.d. at 10:00 p.m. for 12 weeks
Trial: 7691784
Drug: Postoperative radiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postoperative radiation therapy with concomitant mitomycin C
Trial: 7691784
Drug: Postoperative radiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postoperative radiation therapy alone
Trial: 3757322
Drug: Acetate metabolism
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetate metabolism
Trial: 27889723
Drug: 100,000 IU
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100,000 IU of oral cholecalciferol (vitamin D)
Trial: 25132872
Drug: Tranexamic acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tranexamic acid (two doses of 15 mg/kg preoperative and postoperative)
Trial: 20721517
Drug: Concomitant use
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concomitant use of beta-blockers and dobutamine (Group C, n=11)
Trial: 20721517
Drug: Suspension of
RxNorm normalized name: Suspension of heat killed (autoclaved) Mycobacterium w
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suspension of beta-blockers to start dobutamine (Group B, n=25)
Trial: 20721517
Drug: No beta-blockers
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No beta-blockers used (Group A, n=8)
Trial: 18603572
Drug: Long-acting octreotide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long-acting octreotide (30 mg)
Trial: 11874177
Drug: GH alone
RxNorm normalized name: LINER,SECURELY YOURS,PAPER PAK #GH-2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH alone (Saizen, Ares‐Serono, Geneva) 18 IU/m2/week (0.2 mg/kg/week)
Trial: 11874177
Drug: GH +
RxNorm normalized name: Delsym Cough + Cold Daytime
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH + Ox 0.1 mg/kg/day p.o.
Trial: 7556325
Drug: Heparin at
RxNorm normalized name: AT 10
DrugBank: Dihydrotachysterol (DB01070)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin at 0.1, 0.25, 0.5 and 1 IU/ml added to TPN infusions
Trial: 2272193
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg flupenthixol dihydrochloride
Trial: 2272193
Drug: 75 mg
RxNorm normalized name: talc 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg dothiepin hydrochloride
Trial: 7374100
Drug: Intraduodenal L-phenylalanine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraduodenal L-phenylalanine (100 mM)
Trial: 7374100
Drug: Intraduodenal L-phenylalanine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraduodenal L-phenylalanine
Trial: 7374100
Drug: L-phenylalanine absorption
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-phenylalanine absorption rates
Trial: 21232979
Drug: Gabapentin (1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin (1.2 g/d orally before and for 2 days after surgery)
Trial: 20054753
Drug: Rivastigmine, initial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rivastigmine, initial dose of 3 mg/day b.i.d., escalated to maximum tolerated dose in at least 4-week intervals.
Trial: 17926612
Drug: Combined acupuncture
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined acupuncture and medicine group (acupuncture balance points 'Jiangya' and 'Shenbing' with small dose of hypotensor, Irbesartan)
Trial: 17926612
Drug: Medication group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication group (oral administration of Irbesartan and Fosinopril)
Trial: 17926612
Drug: Combined acupuncture
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined acupuncture and medicine group
Trial: 15178812
Drug: Bevacizumab (Avastin)
RxNorm normalized name: Bevacizumab
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Bevacizumab (Avastin) added to standard carboplatin/paclitaxel chemotherapy
Trial: 15178812
Drug: Standard carboplatin/paclitaxel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard carboplatin/paclitaxel chemotherapy alone
Trial: 15178812
Drug: Bevacizumab with
RxNorm normalized name: Bevacizumab
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Bevacizumab with chemotherapy in patients with nonsquamous histologies
Trial: 2833178
Drug: CE therapy
RxNorm normalized name: Ice Therapy
DrugBank: Levomenthol (DB00825)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CE therapy (CDDP plus etoposide)
Trial: 2833178
Drug: CE-AVN therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CE-AVN therapy (ACNU, VCR plus procarbazine)
Trial: 26658268
Drug: TIVA +
RxNorm normalized name: Tivantinib
DrugBank: Tivantinib (DB12200)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TIVA + ramosetron (0.3 mg ramosetron just before anaesthesia induction, remifentanil and propofol anaesthesia)
Trial: 22507665
Drug: 900 mg
RxNorm normalized name: diosmin 900 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 900 mg of lithium
Trial: 15787886
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid 5 mg/day
Trial: 15787886
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid (high doses)
Trial: 12456032
Drug: Sorbent dialysis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sorbent dialysis and standardized conventional medical treatment
Trial: 12456032
Drug: Ongoing medical
RxNorm normalized name: Ongo-Fin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ongoing medical treatment alone
Trial: 10625865
Drug: Waiting treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Waiting treatment group (control)
Trial: 2207304
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg lomefloxacin
Trial: 2207304
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg lomefloxacin
Trial: 1316059
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg lomefloxacin
Trial: 2207304
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg lomefloxacin
Trial: 2207304
Drug: 800 mg
RxNorm normalized name: bran 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 mg lomefloxacin
Trial: 7445655
Drug: D 600
RxNorm normalized name: Guaiphen-D 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D 600 (0.03 mg/kg i.v.)
Trial: 7445655
Drug: Ro 11-1781
RxNorm normalized name: RO-5045337
DrugBank: RO-5045337 (DB14793)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ro 11-1781 (1.0 mg/kg i.v.)
Trial: 30666700
Drug: VAS203 (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VAS203 (10 mg/kg body weight)
Trial: 28142347
Drug: Extracorporeal shock
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Extracorporeal shock wave therapy (ESWT) - 3 sessions
Trial: 28142347
Drug: Corticosteroid injection
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid injection - 80 mg methylprednisolone, 1 injection
Trial: 21392096
Drug: Ezetimibe (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ezetimibe (10 mg daily) plus Simvastatin (40 mg daily)
Trial: 19713268
Drug: Daily movement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily movement training
Trial: 19713268
Drug: Daily social
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily social training
Trial: 17539268
Drug: Regimen-A: 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regimen-A: 300 mg DHA followed by 750 mg MQ and 300 mg DHA 6 and 24 hours later
Trial: 17539268
Drug: Regimen-B: 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regimen-B: 300 mg DHA followed by 300 mg DHA and 750 mg MQ at 24 hours
Trial: 15126524
Drug: DPP-4 inhibitor
RxNorm normalized name: Fibrinolysis inhibitor
DrugBank: Aprotinin (DB06692)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: DPP-4 inhibitor (LAF237); 100 mg daily, n = 18
Trial: 11274902
Drug: Insulin plus
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin plus sulodexide (IS)
Trial: 7521713
Drug: Choline magnesium
RxNorm normalized name: Choline Magnesium Trisalicylate
DrugBank: Choline (DB00122)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Choline magnesium trisalicylate (CMT) 1500 mg
Trial: 2683326
Drug: Cefixime (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefixime (400 mg tablet once daily)
Trial: 2683326
Drug: Trimethoprim (160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimethoprim (160 mg)/sulfamethoxazole (800 mg, one tablet every 12 hours)
Trial: 821573
Drug: Antibiotic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic therapy during surgical treatment
Trial: 821573
Drug: No antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No antibiotic therapy during surgical treatment
Trial: 30345864
Drug: sildenafil citrate
RxNorm normalized name: Sildenafil Citrate
DrugBank: Sildenafil (DB00203)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: sildenafil citrate 20 mg orally three times a day, in addition to fish oil and zinc supplementation
Trial: 30345864
Drug: placebo (tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: placebo (tablets similar to sildenafil)
Trial: 18183403
Drug: 1,350 ml
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,350 ml of low-density barium (VoLumen)
Trial: 18183403
Drug: 900 ml
RxNorm normalized name: OXYGEN 900 mL in 1 L RESPIRATORY (INHALATION) GAS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 900 ml of low-density barium (VoLumen) and 450 ml of water
Trial: 9088654
Drug: Oral cow
RxNorm normalized name: Cow milk
DrugBank: Cow milk (DB10543)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral cow milk challenge (DBPCFC)
Trial: 1545355
Drug: 155-mg oral
RxNorm normalized name: formic acid 155 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 155-mg oral tablet of hydroxychloroquine
Trial: 1545355
Drug: 155-mg iv
RxNorm normalized name: formic acid 155 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 155-mg iv infusion of racemic hydroxychloroquine
Trial: 1395837
Drug: NIAID vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NIAID vaccine
Trial: 3903646
Drug: BIVS vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BIVS vaccine
Trial: 3903646
Drug: Vaccine +
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaccine + hepatitis B immune globulin
Trial: 20717750
Drug: Goal hemoglobin
RxNorm normalized name: HEMOGLOBIN
DrugBank: Hemoglobin (DB04945)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Goal hemoglobin (HGB) concentration of at least 11.5 g/dl
Trial: 20717750
Drug: Goal hemoglobin
RxNorm normalized name: HEMOGLOBIN
DrugBank: Hemoglobin (DB04945)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Goal hemoglobin (HGB) concentration of at least 10 g/dl
Trial: 16086946
Drug: Fixed combination
RxNorm normalized name: Progestogens and estrogens, fixed combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed combination of travoprost 0.004%/timolol 0.5% once daily
Trial: 16086946
Drug: Fixed combination
RxNorm normalized name: Progestogens and estrogens, fixed combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed combination of travoprost 0.004%/timolol 0.5%
Trial: 12451188
Drug: IFNbeta‐1a 44
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFNbeta‐1a 44 micro g subcutaneously three times weekly (tiw)
Trial: 12451188
Drug: IFNbeta‐1a 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFNbeta‐1a 30 micro g IM once weekly (qw)
Trial: 12451188
Drug: IFNbeta‐1a 44
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFNbeta‐1a 44 micro g tiw
Trial: 12451188
Drug: IFNbeta‐1a 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFNbeta‐1a 30 micro g qw
Trial: 11044464
Drug: LNG-IUS treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LNG-IUS treatment for 6 months
Trial: 11044464
Drug: LNG-IUS treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LNG-IUS treatment for 12 months
Trial: 1332987
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no implant)
Trial: 4015741
Drug: Suprofen 200
RxNorm normalized name: suprofen 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suprofen 200 mg/ml intravenous injection or infusion
Trial: 24423366
Drug: Daily supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily supplementation with 70 μg (2800 IU) cholecalciferol for 52 weeks
Trial: 18414870
Drug: Neutral oral
RxNorm normalized name: Nupro Neutral Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neutral oral contrast agent (3% mannitol)
Trial: 18414870
Drug: Positive oral
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Positive oral contrast medium
Trial: 8880676
Drug: Auricular acupuncture
RxNorm normalized name: fluocinolone
DrugBank: Fluocinolone (DB12553)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Auricular acupuncture (5 or more treatments)
Trial: 8880676
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (4 or fewer treatments or refused)
Trial: 27151071
Drug: Virtual reality
RxNorm normalized name: RelieVRx Virtual Reality Behavioral Therapy for Pain Relief
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Virtual reality cognitive therapy
Trial: 23301470
Drug: Loratadine tablets
RxNorm normalized name: Loratadine Tablets
DrugBank: Loratadine (DB00455)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Loratadine tablets (western medication)
Trial: 17697063
Drug: Insulin glargine
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin glargine (once-daily)
Trial: 16274417
Drug: Flecainide (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flecainide (1.5 mg/kg per day)
Trial: 16274417
Drug: Flecainide (3.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flecainide (3.0 mg/kg per day)
Trial: 10219654
Drug: Chlorpheniramine and
RxNorm normalized name: Chlorpheniramine and epinephrine only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorpheniramine and famotidine (H1- and H2-receptor antagonist)
Trial: 10219654
Drug: Hydroxyzine (H1-receptor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydroxyzine (H1-receptor antagonist)
Trial: 7529522
Drug: MIP (mitomycin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MIP (mitomycin 6 mg m‐2, ifosfamide 3 g m‐2, cisplatinum 80 mg m‐2 on day 1 every 28 days)
Trial: 7529522
Drug: PC (cisplatinum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PC (cisplatinum 60 mg m‐2 and carboplatin 400 mg m‐2 on day 1 every 28 days)
Trial: 2212185
Drug: short-term dynamically
RxNorm normalized name: hydrogen peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: short-term dynamically oriented individual therapy
Trial: 727423
Drug: Calcium gluconate
RxNorm normalized name: Calcium Gluconate
DrugBank: Calcium gluconate (DB11126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium gluconate (10 ml 10%)
Trial: 727423
Drug: Calcium chloride
RxNorm normalized name: Calcium Chloride
DrugBank: Calcium chloride (DB01164)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium chloride (10 ml 5.5%)
Trial: 23975134
Drug: Chinese herbal
RxNorm normalized name: GINGER 28 mg in 100 mL TOPICAL OIL [Pain Relief Honzo Seika Chinese Herbal Aroma Oil]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese herbal medicines for nourishing yin, supplementing qi, and activating blood combined with hydroxychloroquine sulfate tablets
Trial: 26525549
Drug: Hydroxychloroquine sulfate
RxNorm normalized name: Hydroxychloroquine Sulfate
DrugBank: Hydroxychloroquine (DB01611)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydroxychloroquine sulfate tablets alone
Trial: 24225205
Drug: Home medication
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Home medication review (HMR) and medication management (MM) conducted by Dementia Care Manager (DCM) in cooperation with pharmacists and general practitioners.
Trial: 19575742
Drug: Modified patient-maintained
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modified patient-maintained target-controlled infusion (TCI) of propofol
Trial: 19575742
Drug: Patient-controlled Entonox
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient-controlled Entonox inhalation
Trial: 16765849
Drug: Group music
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group music with movement intervention (twice a week for 4 weeks)
Trial: 15301650
Drug: Cognitive-behavioral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral therapy (CBT) in group therapy format
Trial: 15301650
Drug: Cognitive-behavioral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral therapy (CBT) in individual face-to-face therapy
Trial: 15301650
Drug: Cognitive-behavioral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral therapy (CBT) through brief individual telephone consultations
Trial: 11142580
Drug: 0.2% glyceryl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2% glyceryl trinitrate ointment (PMF 303)
Trial: 11142580
Drug: Common preparation
RxNorm normalized name: common toad cutaneous gland preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Common preparation of glyceryl trinitrate ointment
Trial: 2809258
Drug: Conventional pertussis
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional pertussis vaccine
Trial: 27296723
Drug: Play &
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Play & Grow intervention (weekly one-hour activity sessions for 10 weeks)
Trial: 18324427
Drug: Caspofungin therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caspofungin therapy for invasive candidiasis (IC)
Trial: 18324427
Drug: Caspofungin therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caspofungin therapy for invasive aspergillosis (IA)
Trial: 18324427
Drug: Caspofungin therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caspofungin therapy as empirical therapy (ET)
Trial: 18324427
Drug: Caspofungin therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caspofungin therapy
Trial: 7755939
Drug: Felodipine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Felodipine (5 to 20 mg; n = 13)
Trial: 7755939
Drug: Ramipril (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ramipril (2.5 to 10 mg; n = 15)
Trial: 2274600
Drug: Propranolol (20-80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (20-80 mg bid)